OBJECTIVE: To review how biotrauma leads to the development of multiple system organ failure (MSOF). DESIGN AND SETTING: Published articles on experimental and clinical studies and review articles in the English language were collected and analyzed. RESULTS: The concept that ventilation strategies using "large" tidal volumes and zero PEEP of injured lungs can enhance injury by the release of inflammatory mediators into the lungs and circulation, a mechanism that has been called biotrauma, is supported by evidence from experimental models ranging from mechanically stressed cell systems, to isolated lungs, intact animals, and humans. Biotrauma may lead to MSOF via spillover of lung-borne inflammatory mediators into the systemic circulation. However, spillover of other agents such as bacteria and soluble proapoptotic factors may also contribute to the onset of MSOF. Other less well studied mechanisms such as peripheral immunosuppression and translocation of bacteria and/or products from the gut may play an important role. Finally, genetic variability is a crucial factor. CONCLUSIONS: The development of MSOF is a multifactorial process. Our proposed mechanisms linking mechanical ventilation and MSOF suggest several novel therapeutic approaches. However, it will first be necessary to study the mechanisms described above to delineate more precisely the contribution of each proposed factor, their interrelationships, and their time course. We suggest that scientific advances in immunology may offer novel approaches for prevention of MSOF secondary to ventilator-induced lung injury.
OBJECTIVE: To review how biotrauma leads to the development of multiple system organ failure (MSOF). DESIGN AND SETTING: Published articles on experimental and clinical studies and review articles in the English language were collected and analyzed. RESULTS: The concept that ventilation strategies using "large" tidal volumes and zero PEEP of injured lungs can enhance injury by the release of inflammatory mediators into the lungs and circulation, a mechanism that has been called biotrauma, is supported by evidence from experimental models ranging from mechanically stressed cell systems, to isolated lungs, intact animals, and humans. Biotrauma may lead to MSOF via spillover of lung-borne inflammatory mediators into the systemic circulation. However, spillover of other agents such as bacteria and soluble proapoptotic factors may also contribute to the onset of MSOF. Other less well studied mechanisms such as peripheral immunosuppression and translocation of bacteria and/or products from the gut may play an important role. Finally, genetic variability is a crucial factor. CONCLUSIONS: The development of MSOF is a multifactorial process. Our proposed mechanisms linking mechanical ventilation and MSOF suggest several novel therapeutic approaches. However, it will first be necessary to study the mechanisms described above to delineate more precisely the contribution of each proposed factor, their interrelationships, and their time course. We suggest that scientific advances in immunology may offer novel approaches for prevention of MSOF secondary to ventilator-induced lung injury.
Authors: Roy G Brower; Michael A Matthay; Alan Morris; David Schoenfeld; B Taylor Thompson; Arthur Wheeler Journal: N Engl J Med Date: 2000-05-04 Impact factor: 91.245
Authors: A N von Bethmann; F Brasch; R Nüsing; K Vogt; H D Volk; K M Müller; A Wendel; S Uhlig Journal: Am J Respir Crit Care Med Date: 1998-01 Impact factor: 21.405
Authors: Frans B Plötz; Harriet A E Vreugdenhil; Arthur S Slutsky; Jitske Zijlstra; Cobi J Heijnen; Hans van Vught Journal: Intensive Care Med Date: 2002-02-09 Impact factor: 17.440
Authors: Michael R Wilson; Sharmila Choudhury; Michael E Goddard; Kieran P O'Dea; Andrew G Nicholson; Masao Takata Journal: J Appl Physiol (1985) Date: 2003-06-13
Authors: Antonia Koutsoukou; Maria Katsiari; Stylianos E Orfanos; Anastasia Kotanidou; Maria Daganou; Magdalini Kyriakopoulou; Nikolaos G Koulouris; Nikoletta Rovina Journal: World J Crit Care Med Date: 2016-02-04
Authors: Olivier Lesur; Stephan Langevin; Yves Berthiaume; Martin Légaré; Yoanna Skrobik; Jean-François Bellemare; Bruno Lévy; Yvan Fortier; Francois Lauzier; Gina Bravo; Marc Nickmilder; Eric Rousseau; Alfred Bernard Journal: Intensive Care Med Date: 2006-06-23 Impact factor: 17.440
Authors: Pedro L Silva; Fernanda F Cruz; Livia C Fujisaki; Gisele P Oliveira; Cynthia S Samary; Debora S Ornellas; Tatiana Maron-Gutierrez; Nazareth N Rocha; Regina Goldenberg; Cristiane S N B Garcia; Marcelo M Morales; Vera L Capelozzi; Marcelo Gama de Abreu; Paolo Pelosi; Patricia R M Rocco Journal: Crit Care Date: 2010-06-14 Impact factor: 9.097
Authors: Rogier M Determann; Annick Royakkers; Esther K Wolthuis; Alexander P Vlaar; Goda Choi; Frederique Paulus; Jorrit-Jan Hofstra; Mart J de Graaff; Johanna C Korevaar; Marcus J Schultz Journal: Crit Care Date: 2010-01-07 Impact factor: 9.097
Authors: Maria A Hegeman; Marije P Hennus; Cobi J Heijnen; Patricia Ac Specht; Burkhard Lachmann; Nicolaas Jg Jansen; Adrianus J van Vught; Pieter M Cobelens Journal: Crit Care Date: 2009-11-16 Impact factor: 9.097